Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/14/1991 | WO1991016885A1 Dosage form to deliver an antiparkinson agent |
11/14/1991 | WO1991014704A3 Treatment of polycystic ovarian disease |
11/14/1991 | WO1991013890A3 Diastereoisomeric compounds derived from tetrahydrofolic acid, process for their preparation and use in the synthesis of diastereoisomers 6s and 6r of reduced folates |
11/14/1991 | WO1991011453A3 5-oxygenated-2,4,6-triaminopyrimidines |
11/14/1991 | DE4015136A1 Verfahren zur herstellung von thieno-triazolo-diazepinderivaten Thieno-triazolo-diazepine derivatives process for the preparation of |
11/14/1991 | DE4014672A1 Adamantane derivs. for cyto-protection of cells - protects infected and non-infected lymphocytes and other cells, and can be used in treating e.g. AIDs and ARC |
11/14/1991 | CA2374571A1 Dna encoding human 5-ht1d receptors and uses thereof |
11/14/1991 | CA2337748A1 1,3-oxathiolane nucleoside analogues |
11/14/1991 | CA2082392A1 Tetrahydrobenzothienopyridines, processes for their preparation and their use as pharmaceuticals |
11/14/1991 | CA2081569A1 Composition for solid pharmaceutical preparations containing vitamin d3 derivative and process for preparation thereof |
11/14/1991 | CA2081349A1 Pharmaceutical formulation |
11/14/1991 | CA2042321A1 Substituted 3-aminosydnone imines, processes for their preparation and their use |
11/13/1991 | EP0456519A1 Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives, their preparation and their therapeutic use |
11/13/1991 | EP0456514A1 2-Fluoroneplanocin A and its production |
11/13/1991 | EP0456510A1 Antihypertensive products, a process for their preparation and pharamaceutical compositions containing them |
11/13/1991 | EP0456509A1 Derivatives of 3' - and 3"-0-desmethyl avermectin compounds |
11/13/1991 | EP0456468A2 Complex of dideoxynucleoside and phosphonoformic acid |
11/13/1991 | EP0456442A1 Quinoline derivatives, process for their preparation and their use as medicaments |
11/13/1991 | EP0456418A2 Treatment of clostridium difficile diarrhoea and pseudomembranous colitis |
11/13/1991 | EP0456279A1 Condensed piperidine derivatives, intermediates and process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
11/13/1991 | EP0456214A1 Fluorinated derivatives of mevinic acids |
11/13/1991 | EP0456209A2 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis |
11/13/1991 | EP0456204A2 Use of benzocycloheptathiophenecarboxylic acid derivatives in the treatment of eosinophile accumulation/activation and connected diseases |
11/13/1991 | EP0456196A1 Pyrrolo,[2,3-b]indole-ketones and analogs, a process for their preparation and their use as medicaments |
11/13/1991 | EP0456185A2 Renin inhibitors |
11/13/1991 | EP0456183A2 Spiro dibenzosuberane derivatives |
11/13/1991 | EP0456149A1 9-Substituted compounds of 3 alpha, 11 alpha-Epoxy-3,4,5, 5a alpha,6,7,8,8a,9,11,11a-undecahydro-3 beta, 6 alpha, 9-trimethylfurano[3,4-j][1,2]-benzodioxepin, processes for their preparation and their use as antiprotozoal and antiviral agents |
11/13/1991 | EP0456133A1 Hydrazones |
11/13/1991 | EP0456124A2 Polyisoprene compounds, salts thereof, process for the preparation thereof, and use thereof |
11/13/1991 | EP0456106A2 Stable emulsion for pharmaceutical administration, process for its preparation and use thereof as pharmaceutical |
11/13/1991 | EP0455909A2 5-[1-(Imidazol)methyl]-3,3-disubstituted-2(3H) furanone derivatives |
11/13/1991 | EP0455899A1 Prostaglandin I analogue |
11/13/1991 | EP0455830A1 Medicine containing thiazine dioxide derivative |
11/13/1991 | EP0455805A1 A method of stimulating steroidogenesis with alpidem |
11/13/1991 | EP0455774A1 Thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same |
11/13/1991 | EP0455770A1 Use of guanidinoacetic acid to induce an increase of the creatine contents in muscles |
11/13/1991 | EP0455753A1 Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
11/13/1991 | EP0455648A1 Dosage form for administering calcium antagonist. |
11/13/1991 | EP0455631A1 Preparation containing salicylic acid for treating desquamative skin diseases. |
11/13/1991 | EP0414806A4 High ratio active agent:lipid complex |
11/13/1991 | CN1056104A Process for preparing nojirimycin derivatives |
11/13/1991 | CN1056103A Tricyclic compounds, their preparation and pharmaceutical composition containing them |
11/13/1991 | CN1056101A 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use |
11/13/1991 | CN1056100A Method of producing alkanesulfonanilide derivatives |
11/13/1991 | CN1056056A Composition and method for controlling cholesterol |
11/13/1991 | CN1056055A Percutaneously absorbable eperisone or tolperisone preparation |
11/13/1991 | CN1014710B Process for 6-beta (substrated)-shydroxymethyl-penicillanic acid and its derivatives |
11/13/1991 | CN1014707B Process for preparing 1,2,4-thiadiazines |
11/13/1991 | CN1014673B Anti-biotic 6270 process for its production, and its use as anticoccidiosis agent and feed additive |
11/13/1991 | CA2042282A1 Oxalylamino acid derivatives, processes for their preparation and their use as medicaments for inhibiting proline hydroxylase |
11/12/1991 | WO1991018100A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
11/12/1991 | WO1991018014A1 Anti-viral therapy |
11/12/1991 | WO1991017771A1 Synergistic therapeutic compositions and methods |
11/12/1991 | US5064961 Process for preparing an optically active cyclobutane nucleoside |
11/12/1991 | US5064945 Chartreusin derivatives and salts thereof |
11/12/1991 | US5064862 Anticonvulsant method and formulations |
11/12/1991 | US5064860 Disease therapy |
11/12/1991 | US5064858 Comlexes with polysaccharides, glycols, ascorbic acid, panttothenic acid, amino acids or caffeine |
11/12/1991 | US5064857 Liquid bismuth containing medicinal product, process for producing it and its use |
11/12/1991 | US5064856 Novel hmg-coa synthase inhibitors |
11/12/1991 | US5064854 3,4-disubstituted phenyl heterocycles and their use |
11/12/1991 | US5064853 4(2-indolyl)2-amino-pentanedioic acids and cholecyostokinin use thereof |
11/12/1991 | US5064851 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use |
11/12/1991 | US5064849 Heterocyclic derivatives useful as radiosensitizing agents and antiviral agents |
11/12/1991 | US5064848 Benzophenone oxime ether compounds, pharmaceutical compositions and treatment methods |
11/12/1991 | US5064843 Pyrid-3-yl thioformamide compounds which have useful pharmaceutical utilities |
11/12/1991 | US5064842 1,4-dihydropyridines |
11/12/1991 | US5064841 Antilipemic agents; atherosclerosis |
11/12/1991 | US5064839 1,4-dihydropyridines with a 2-amino group or with an ether group in a side chain |
11/12/1991 | US5064838 And muscle relaxants; non-narcotic, nonhabit-forming |
11/12/1991 | US5064837 Antiallergens |
11/12/1991 | US5064836 Imidazopyridine for use as an anaesthetic |
11/12/1991 | US5064835 Hydroxymacrolide derivatives having immunosuppressive activity |
11/12/1991 | US5064832 Biaryl compounds |
11/12/1991 | US5064831 N-methyl-d-aspartate receptor antagonist |
11/12/1991 | US5064830 Lowering of blood uric acid levels |
11/12/1991 | US5064829 Composition of a b vitamin and mannitol and a method for production |
11/12/1991 | US5064826 Analgesic, antiderpressant |
11/12/1991 | US5064825 Angiotensin ii antagonists |
11/12/1991 | US5064824 Cephalosporin compounds |
11/12/1991 | US5064823 Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
11/12/1991 | US5064821 Method and compositions for overcoming tetracycline resistance within living cells |
11/12/1991 | US5064819 Substituted propane-phosphinic acid compounds |
11/12/1991 | US5064817 Phospholipase a2 inhibiting compositions and their use |
11/12/1991 | US5064816 Furan or thiophene ring |
11/12/1991 | US5064815 Primycin-containing colloidal basic gel |
11/12/1991 | US5064813 Antiandrogen, antiestrogen, steroid inhibitor |
11/12/1991 | US5064810 Use of branched chain amino acids to effect diaphragm contractility and fatigue |
11/12/1991 | US5064758 Method of preparing a mixture of ribonucleotides |
11/12/1991 | US5064649 Cephalosporin derivatives |
11/12/1991 | US5064643 Method for treating sickle cell disease |
11/12/1991 | US5064642 Saturated hydrocarbon, phenanthrene based; skin and hair cosmetics, drugs |
11/12/1991 | CA2042336A1 Piperidyloxy-and quinuclidinyloxy-isoxazole, derivatives, their preparation and their therapeutic use |
11/12/1991 | CA2042304A1 Process for preparing 2,2-dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid |
11/12/1991 | CA2041920A1 Stable emulsion suitable for pharmaceutical administration, the production thereof and emulsion for pharmaceutical use |
11/12/1991 | CA2041825A1 Renin inhibitors |
11/12/1991 | CA2041763A1 Microbial transformation process for antihypertensive products |
11/12/1991 | CA2041762A1 Derivatives of 3'-and 3"-0-desmethyl avermectin compounds |
11/12/1991 | CA2040530A1 Fluorinated derivatives of mevinic acids |
11/12/1991 | CA1292049C Inclination measuring device |